melanotan clinical trials A peptide that makes you tan. Sounds great. What could go wrong? When it’s activating your melanocytes to increase pigment in your skin, it may also be causing cancer— melanoma. I’ve had patients have Clinically important side effects of

A High Purity PT-141 formulation supports reproducibility and accuracy in experimental design by reducing the presence of synthesis byproducts that could interfere with melanocortin receptor interactions or CNS-focused research outcomes

The risk of melanoma occurring in any given dysplastic nevus has been calculated to be approximately 1 in 30,000 for men and 1 in 40,000 for women, which confirms that their primary importance is a risk marker rather than a precancerous condition in itself

In patients with syndromes like Laugier-Hunziker and Peutz-Jeghers mucosal melanosis can be diagnosed in high frequencies and in patients with inflammatory skin diseases like lichen planus genital melanosis have been reported (5,7-9)

In a human Phase I study, subcutaneous MT-II increased skin pigmentation (measured by quantitative reflectance) after only a few low doses, alongside central melanocortin effects[1]